Pfizer
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable. ...
Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication ...
Could it be COVID? Here are the symptoms to watch out for in 2024
COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after ...
GSK, Pfizer RSV shots must warn about rare paralysis risk
An analysis found nine excess cases of Guillain-Barré for every million doses given. Read More
Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Got COVID? Here are the new 2024 isolation guidelines
The CDC no longer advises a five-day isolation period when you test positive, but recommends taking other precautions once your ...
New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines ...
Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
More than 41,000 people in the U.S. died of pneumonia in 2022, according to the CDC. Read More
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings. Read More